KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Change in Receivables (2016 - 2025)

Chemed (CHE) has 17 years of Change in Receivables data on record, last reported at -$32.8 million in Q4 2025.

  • For Q4 2025, Change in Receivables fell 31.15% year-over-year to -$32.8 million; the TTM value through Dec 2025 reached $11.6 million, up 208.6%, while the annual FY2025 figure was $11.6 million, 208.6% up from the prior year.
  • Change in Receivables reached -$32.8 million in Q4 2025 per CHE's latest filing, down from $30.9 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $67.4 million in Q1 2025 and bottomed at -$54.0 million in Q2 2025.
  • Average Change in Receivables over 5 years is $2.7 million, with a median of $9.8 million recorded in 2024.
  • Peak YoY movement for Change in Receivables: soared 4327.4% in 2021, then crashed 794.71% in 2025.
  • A 5-year view of Change in Receivables shows it stood at $17.7 million in 2021, then increased by 5.1% to $18.6 million in 2022, then fell by 26.56% to $13.6 million in 2023, then crashed by 283.32% to -$25.0 million in 2024, then tumbled by 31.15% to -$32.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$32.8 million in Q4 2025, $30.9 million in Q3 2025, and -$54.0 million in Q2 2025.